Anti-corpus luteum antibody and menstrual irregularity in patients with systemic lupus erythematosus and Hashimoto's thyroiditis

Lupus

Volumn 14, Issue 8, 2005, Pages 618-624

  Cabral De Sousa, D ^a   Das Chagas Medeiros, M M ^a   Trindade Viana, V S ^b   Salani Mota, R M ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anti corpus luteum; Hashimoto's thyroiditis; Menstrual disturbances; Systemic lupus erythematosus

Indexed keywords

ANTIBODY; CORPUS LUTEUM ANTIBODY; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; PROLACTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOCRINE DISEASE; FEMALE; HASHIMOTO DISEASE; HUMAN; MENSTRUAL IRREGULARITY; PATHOLOGY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORPUS LUTEUM; FEMALE; HASHIMOTO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENSTRUATION DISTURBANCES; SEVERITY OF ILLNESS INDEX;

EID: 24744467225     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2178oa     Document Type: Article

References (25)

1. Wallace DJ, Dobois EL. Clinical and laboratory manifestations of SLE. In: Dubois lupus erythematosus, 3rd edn. Philadelphia: Lea & Febiger, 1987: 317-499.
2. Gonzalez-Crespo MR, Gomez-Reino JJ, Merino R et al. Menstrual disorders in girls with systemic lupus erythematosus treated with cyclophosphamide. Br J Rheumatol 1995; 34: 737-741.
3. Pasoto SG, Mendonça BB, Bonfa E. Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus 2002; 11: 175-180.
4. Pasoto SG, Viana VST, Mendonça BB, Yoshinari NH, Bonfa E: Anticorpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus? J Rheumatol 1999; 26: 1087-1093.
5. Krassas GE. Thyroid disease and female reproduction. Fertil Steril 2000; 749: 1063-1070.
6. Miller FW, Moore GF, Weintraub BD, Steinberg AD. Prevalence of thyroid disease and abnormal tyroid function test results in patients with systemic lupus erythematosus. Arthritis Rheum 1987; 30: 1124-1131.
7. Park DJ, Cho CS, Lee SH, Park SH, Kim HY. Thyroid disorders in Korean patients with systemic lupus erythematosus. Scand J Rheumatol 1995; 24: 13-17.
8. Medeiros MMC, Silveira VAL, Menezes APT, Carvalho RC. Risk factors for ovarian failure in patients with systemic lupus erythematosus. Br J Med Biol Res 2001; 34: 1561-1568.
9. Sterzl I, Novakova D, Vavrejnova V, Zamrazil V Thyroid, ovarian and adrenal antibodies in female patient autoimmune thyroiditis. Cas Lek Cesk 1997; 136: 249-252.
10. Bannatyne P, Russell P, Shearman RP Autoimmune oophoritis: a clinicopathologic assessment of 12 cases. Int J Gvnecol Pathol 1990; 9: 191-207.
11. Snajderova M, Martinek J, Horesjsi J Novakova D, Lebl J, Kolouskova S. Premenarchal and postmenarchal girls with insulin-dependent diabetes mellitus: ovarian and other organ-specific autoantibodies, menstrual cycle. J Pediatr Adolesc Gynecol 1999; 12: 209-214.
12. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Committee on prognosis in SLE. Derivation of the SLEDAI. A disease activity index for lupus patientes. Arthritis Rheum 1992; 35: 630-640.
14. Lim GS, Petri M, Goldman D. Menstruation and systemic lupus erythematosus: a case-control study (abstract). Arthritis Rheum 1993; 36 (Suppl 5): R23.
15. Steinberg AD, Steinberg BJ. Lupus disease activity associated with menstrual cycle. J Rheum 1985; 12: 816-817.
16. Moncayo-Nevada H, R, Benz R, Wolf A, Lauritzen CH: Organ-specific antibodies against ovary in patients with systemic lulpus erythematosus. Am J Obstet Gynecol 1989; 160: 1227-1229.
17. Yocum MW, Grossman J, Waterhouse C, Abraham GN, May AG, Condemi JJ. Monozygotic twins discordant for systemic lupus erythematosus. Comparison of immune response, autoantibodies viral antibodies titers, gamma globulin, and light chain metabolism. Arthritis Reum 1975; 18: 193-199.
18. Moncayo H, Mocayo R, Benz R, Wolf A, Lauritzen CH. Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum. J Clin Invest 1989; 84: 1857-1865.
19. Moncayo R, Moncayo HE. A new endocrinological and immunological syndrome in SLE: elevation of human chorionic gonadotropin and of antibodies directed against ovary and endometrium antigens. Lupus 1995; 4: 39-45.
20. Prilepskaia VN, Lobova TA, Laricheva IP. Secondary amenorrhea caused by hypothyroidism. Akussh Ginekol (Mosk) 1990; 4: 35-38.
21. Bispink L, Brandle W, Lindner C, Bettendorf G. Preclinical hypothyroidism and disorders of ovarian function. Geburtshilfe Frauenklinik 1989; 49: 881-888.
22. Brabant G, Corette L, Houze de l'Aulnoit D, Ellart D. Dysthyroidism and fertility. Rev Frr Gynecol Obstet 1989; 84: 898-900.
23. Koutras DA. Disturbances of menstruation in thyroid disease. Ann N Y Acad Sci 1997; 816: 280-284.
24. Matalon ST, Blank M, Ornoy A, Shoenfeld Y. The association between anti-thyroid antibodies and pregnancy loss. Am J Reprod Immunol 2001; 45: 72-77.
25. Ghazeeri GS, Kutteh WH. Autoimmune factors in reproductive failure. Curr Opin Obstet Gynecol 2001; 13: 287-291.